---
category: market-operations
circular_id: 1c704a804c65a9ef
date: '2025-12-11'
description: NSE will conduct mock trading session in Futures & Options segment on
  December 13, 2025 with specific timings for primary site, DR site, and live re-login
  sessions.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/FAOP71768.pdf
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine mock trading session with no system changes; primarily operational
  testing with emphasis on algorithmic trading functionality testing as per SEBI guidelines
pdf_url: https://nsearchives.nseindia.com/content/circulars/FAOP71768.pdf
processing:
  attempts: 1
  content_hash: f62ab4a55175bb4c
  processed_at: '2025-12-11T19:13:07.757179'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-11T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/FAOP71768.pdf
severity: low
source: nse
stocks: []
tags:
- mock-trading
- futures-and-options
- NEAT-plus
- algorithmic-trading
- disaster-recovery
- testing
title: Mock Trading on Saturday, December 13, 2025 - No New Version Release
---

## Summary

NSE will conduct a mock trading session in the Futures & Options segment on Saturday, December 13, 2025. The session includes trading from both primary site (11:00-13:45) and DR site (14:15-15:40), followed by live re-login (16:30-17:00). No new version release is planned. Members are required to test algorithmic trading functionality and provide evidence of participation to comply with SEBI regulations on safer participation of retail investors in algorithmic trading.

## Key Points

- Mock trading scheduled for December 13, 2025 in Futures & Options segment
- Trading Session-1 from Primary Site: Pre-open 11:00-11:08, Normal market 11:15-13:45
- Trading Session-2 from DR Site: Pre-open 14:15-14:23, Normal market 14:30-15:30, Trade modification until 15:40
- Live Re-login: 16:30-17:00
- Pre-open close time will have random closure in last one minute
- NEAT+ version 7.8.6 will be discontinued on January 03, 2026
- Members must test algorithmic trading functionality during mock session
- Evidence of participation must be submitted to NNFREG@nse.co.in

## Regulatory Changes

No new regulatory changes introduced. This circular implements existing SEBI guidelines on safer participation of retail investors in algorithmic trading as per SEBI circular SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/132 dated September 30, 2025.

## Compliance Requirements

- Trading members must participate in mock or simulation environment to test algorithmic trading functionality
- Members must provide evidence of participation with following details to NNFREG@nse.co.in:
  - Trading Member Name
  - Trading Member code
  - User id
  - Participation in session (Mock/simulation environment)
  - Date(s) of participation
  - Segment
- Members should refer to connectivity parameters in circular NSE/MSD/67674 dated April 24, 2025
- Members must review referenced SEBI and NSE circulars on algorithmic trading implementation standards and operational modalities

## Important Dates

- **December 13, 2025**: Mock trading session
  - 11:00-11:08: Pre-open from Primary Site
  - 11:15-13:45: Normal market from Primary Site
  - 14:15-14:23: Pre-open from DR Site
  - 14:30-15:30: Normal market from DR Site
  - 15:30-15:40: Trade modification end time
  - 16:30-17:00: Live Re-login
- **January 03, 2026**: Discontinuation date for NEAT+ version 7.8.6

## Impact Assessment

**Market Impact**: Low - This is a routine mock trading session with no live market impact.

**Operational Impact**: Medium for trading members - Members need to allocate resources for mock session participation and testing of algorithmic trading functionality. Evidence submission requirement adds administrative burden.

**Technical Impact**: Low - No new version release planned. Members can continue using existing NEAT+ versions 7.8.6 or 7.8.7.

**Compliance Impact**: Medium - Members must ensure compliance with SEBI's algorithmic trading requirements by participating in testing and providing evidence, part of the regulatory glide path for implementation.